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Abstract
Introduction
Scabies is a major public health problem in the Pacific and is associated with an increased
risk of bacterial skin infections, glomerulonephritis and rheumatic fever. Mass drug adminis-
tration with ivermectin is a promising strategy for the control of scabies. Mass treatment with
ivermectin followed by active case finding was conducted in five communities in the Solo-
mon Islands between 1997 and 2000 and resulted in a significant reduction in the preva-
lence of both scabies and bacterial skin infections.
Methods
We conducted a prospective follow-up study of the communities where the original scabies
control programme had been undertaken. All residents underwent a standardised examina-
tion for the detection of scabies and impetigo.
Results
Three hundred and thirty eight residents were examined, representing 69% of the total pop-
ulation of the five communities. Only 1 case of scabies was found, in an adult who had
recently returned from the mainland. The prevalence of active impetigo was 8.8% overall
and 12.4% in children aged 12 years or less.
Discussion
We found an extremely low prevalence of scabies 15 years after the cessation of a scabies
control programme. The prevalence of impetigo had also declined further since the end of
the control programme. Our results suggest that a combination of mass treatment with iver-
mectin and intensive active case finding may result in long term control of scabies. Larger
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scale studies and integration with other neglected tropical disease control programmes
should be priorities for scabies control efforts.
Author Summary
Scabies is a parasitic infection caused by the mite Sarcoptes scabiei. Scabies is a risk factor
for bacterial skin infections and as a result of these secondary infections, individuals with
scabies are also at risk of kidney disease and possibly rheumatic heart disease. Tradition-
ally the management of scabies has involved treating individuals and close contacts with
topical medicines. Although this normally cures the patient, individual treatment does not
have any impact on the overall amount of scabies in a community. There is now significant
interest in trying mass drug administration (MDA) against scabies using ivermectin, a tab-
let which is a very effective treatment. A key question for scabies control programmes is
how long the beneficial effect of MDA lasts. In this study we provide fifteen year follow-up
on one of the first communities in the world to ever receive ivermectin MDA for the con-
trol of scabies. These communities had received intensive scabies control between 1997
and 2000 but then no further MDA or surveillance. We found that the amount of scabies
had remained extremely low following the treatment programme and that bacterial skin
infections had also remained low. This data suggests that long term control of scabies can
be achieved with an initial intensive control programme.
Introduction
Scabies, caused by infestation with the Sarcoptes scabieimite, remains a major public health
problem in developing countries worldwide[1]. In addition to the direct manifestations of
infestation, scabies is associated with an increased risk of bacterial skin infections due to Staph-
ylococcus aureus and Streptocococcus pyogenes[2] and. as a result, with both glomerulonephritis
and possibly rheumatic heart disease[1,3]. Treatment of scabies also results in a reduction of
secondary skin infections [4], even in the absence of specific anti-bacterial therapy, and the
benefits of treatment might therefore extend well beyond scabies itself.
Worldwide the highest burden of scabies is reported from the Pacific[5] with a prevalence
as high as 30–40% reported in some studies[4,6]. Alongside the substantial burden of scabies, a
high prevalence of impetigo and secondary bacterial skin infections is also reported in these
settings. Most studies have reported that the prevalence of both scabies and secondary bacterial
infection is higher in children than in adults[5].
In endemic areas with high prevalence mass treatment has been advocated as a promising
intervention to control scabies at a population level[7,8]. It is well recognised that simultaneous
treatment of all household members is required to prevent re-infestation from occurring. The
treatment of patients presenting to health care facilities with scabies does not have a long term
impact on the community prevalence of scabies, presumably because re-infestation is common
in endemic settings. A study evaluating the impact of mass treatment with topical permethrin
conducted in Panama demonstrated a substantial reduction in the prevalence of scabies[8].
The control programme was interrupted by the subsequent American invasion of Panama,
resulting in the breakdown of the control programme and a resurgence of scabies.
The use of the oral agent ivermectin, has been advocated as an alternative to topical treat-
ments for scabies [9,10]. A number of studies have shown that ivermectin is equivalent or
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superior to commonly used topical treatments such as benzyl benzoate[11–13]. Ivermectin has
been used as part of mass drug administration (MDA) programmes for the elimination of lym-
phatic filariasis and onchocerciasis, and an indirect assessment from Zanzibar showed a marked
decrease in incident cases of scabies seen in clinics was reported[14]. Two small scale assessments
of MDA with ivermectin, conducted in Papua New Guinea[15] and the Solomon Islands[4],
have both demonstrated a significant reduction in the prevalence of scabies, an accompanying
reduction in the prevalence of secondary bacterial skin infections. These studies have also shown
some evidence for a reduction in the prevalence of post-streptococcal glomerulonephritis. A fur-
ther study in Fiji which compared MDA with either ivermectin or topical benzyl-benzoate
showed that both strategies effectively reduced the prevalence of scabies at a community level[7].
The first attempt at MDA for scabies control using ivermectin was conducted between 1997
and 2000 in five communities in the Lau Lagoon in the Solomon Islands. The selected commu-
nities, Addagege, Foueda, Funafou, Nuileni and Sulufo lived on isolated artificial islands off the
mainland of Malaita (Fig 1). Whilst residents travel to and from the mainland to farm the pop-
ulation is relatively isolated from the mainland population. The methodology of the pro-
gramme has been described in detail elsewhere [4]. Briefly, a step-wedge design was used.
There was an initial round of community mass treatment of all the inhabitants of each commu-
nity with a single dose of ivermectin (200μg/kg), or permethrin where ivermectin was contrain-
dicated. Residents who had been absent at the time of the initial mass treatment were offered
treatment on their return, irrespective of whether they clinically were found to have scabies or
not. The initial mass treatment was followed by active case finding surveys conducted three
times a year by local nursing staff. Individuals found to have scabies at a follow-up visit were
retreated along with their household contacts. The prevalence of scabies in children fell from
25% at the start of the study to 0.7% at the final visit. There was an accompanying decline in
the prevalence of impetigo from 40% to 22%. The prevalence of scabies in adults fell from
approximately 20% at the start of the study to 0.8% at the final visit. Since the cessation of the
study in 2000 no further active control measures have been undertaken in these communities.
We conducted a cross-sectional survey to establish the prevalence of scabies and impetigo 15
years after the cessation of the scabies control programme in these communities.
Fig 1. Location of villages. The map highlights the position of the five villages included in the original
scabies control programme. Local health clinics and the provincial capital Auki are also shown.
doi:10.1371/journal.pntd.0004246.g001
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Methods
Participant Recruitment
The follow-up survey was undertaken in August 2015. Verbal consent was obtained from vil-
lage chiefs to conduct the survey. We then undertook a house-to-house survey with village
elders to obtain an accurate headcount of individuals currently living in each community. All
residents of the five communities were invited to participate in the study.
Ethics Statement
Written informed consent was obtained from participants by staff fluent in local dialect. For
children<18 years, written consent was obtained from an adult parent or guardian and verbal
assent was obtained from the child. Ethical approval for the study was granted by the London
School of Hygiene & Tropical Medicine (LSHTM-9146) and the Solomon Islands National
Health Ethics Research Committee (HRC-15/14).
Data Collection
For each participant we collected demographic data including age and gender, as well as data
on household size and number of individuals sharing a single room as measures of overcrowd-
ing. We collected data on whether any household contacts had been diagnosed with scabies.
All participants were then examined by an experienced consultant paediatrician (BTW). We
recorded the presence or absence of all skin lesions, their distribution and whether they were
consistent with scabies, impetigo or an alternative diagnosis. The number of scabies lesions was
classified as10, 11 to 49 or50. Lesions of impetigo were classified as either active (moist,
purulent or crusted lesions) or healed (flat/dry lesions with no crust). The number of impetigo
lesions was classified as5, 6 to 10, 11 to 49 or50. All data was collected directly on to
Android smartphones using the ODK software package[16].
Statistical Analysis
As the aim of the study was to examine the resident population of each community no formal
sample size calculation was undertaken. We estimated the prevalence of scabies and impetigo
stratified by age and gender with exact confidence intervals based on the binomial distribution.
Logistic regression was used to calculate odds ratios associated with scabies and impetigo. For
the purpose of analysis we stratified age into young children (age12), adolescents (aged 13–
18) and adults (18). A cut-off of twelve years was selected for defining young children as this
was the age cut-off used to define children in the original scabies control programme study.
Household size was classified as5 or>5 residents, which is the national average household
size based on the 2009 census[17]. We classified the number of individuals sharing a room as 1,
2 or3. All analyses were conducted using STATA 13.1 (Statcorp, Texas, USA). The paper is
reported in line with the STROBE checklist for observational studies[18] (S1 Checklist).
Results
According to the initial house-to-house survey 561 individuals were reported to be currently
resident in the five communities. In total 388 individuals (69.2%), from 121 households were
present during the survey period. All individuals present at the time of the survey consented to
participate in the current study. The median age was 15 years (IQR 7–38) and 221 participants
were female (57%). The median reported household size was 4 residents (IQR 3–6) and the
median number of examined individuals per household was 3 (IQR 2–4). A majority of indi-
viduals slept in the same room as 3 or more individuals (n = 196, 50.5%) (Table 1).
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Scabies was diagnosed in one individual (0.26%, 95% CI 0.0–1.4%). Twelve individuals
(3.1%) from seven households reported a household contact had been diagnosed with scabies
in the last twelve months.
Active impetigo was diagnosed in 34 individuals (8.8%, 95% CI 6.1–12.0%). Most patients
with impetigo (n = 31, 91.2%) had a small number of lesions (5). Active impetigo was more
common in children aged twelve years or less (OR 2.60, p< 0.021) compared to adults. Impe-
tigo was also more common in children aged 13–18 years than in adults, and in males than in
females, although these differences were not statistically significant (Table 2). Household size
was not associated with the risk of active impetigo (p = 0.44). The risk of active impetigo
increased with the number of inhabitants sharing a room but this association was not statisti-
cally significant (p = 0.19) (Table 2). The prevalence of impetigo did not differ significantly
between villages (p = 0.37).
Evidence of healed impetigo was found in 119 individuals (30.7%, 95% CI 26.1–35.5%).
Other commonly noted skin lesions included molluscum contagiosum (n = 15, 3.9%), ring-
worm (n = 9, 2.3%) and warts (n = 8, 2.1%).
Discussion
In this study we found an extremely low prevalence of scabies fifteen years after the cessation
of an intensive control programme in five communities in the Solomon Islands. Only one case
of scabies was found after examining almost four hundred participants. On questioning, this
individual had recently returned from spending several nights in a village on the mainland, and
therefore it is possible therefore that this case represents an imported infection. The prevalence
of scabies found in this follow-up study is similar to that at the end of the original control pro-
gramme in 2000 and suggests that the intervention undertaken has resulted in a sustained
Table 1. Demographic characteristics.
Variable n (%)
Village
Addagege 32 (8.2%)
Foueda 46 (11.9%)
Funafou 95 (24.5%)
Nuileni 60 (15.5%)
Sulofu 155 (39.9%)
Gender
Male 167 (43.0%)
Female 221 (57.0%)
Age (years)
12 169 (43.7%)
13–18 44 (11.3%)
19 174 (45.0%)
Household Size
5 239 (61.6%)
>5 149 (38.4%)
Individuals sleeping in same room (n)
1 59 (15.2%)
2 133 (34.3%)
3 196 (50.5%)
doi:10.1371/journal.pntd.0004246.t001
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reduction in the prevalence of scabies on these islands. Of interest, the original study used only
a single dose of ivermectin[4], rather than the two dose regime that is now recommended[19].
It is likely that the frequent follow-up and retreatment undertaken in the control programme
mitigated the effect of a reduced initial dose and contributed to the sustained reduction in sca-
bies prevalence observed.
Alongside this extremely low prevalence of scabies we found a relatively low prevalence of
impetigo. The prevalence of impetigo in children aged 12 or less at the beginning of the scabies
control programme had been 40% but declined to 21% by the end of the intervention. In our
survey this had declined still further to 12%, suggesting that the long term reduction in scabies
has had a continuing effect in reducing, although not eliminating, bacterial skin infections.
In all five communities the study teammet residents who recalled the original scabies control
intervention. Community leaders all reported that since the completion of the control pro-
gramme, scabies was no longer a significant health problem in the villages. Nurses in the local
clinics serving the communities offered similar evidence; staff at both clinics reported that sca-
bies cases were seen rarely from the study communities but that cases continued to be seen from
villages on the mainland of the province. Although anecdotal, this evidence is in keeping with
the low prevalence of scabies infestation found on examination and the extremely small number
of individuals who reported a household contact who had been diagnosed with scabies.
Our study has a number of weaknesses, most notably the long period since the last survey
was conducted. It is possible that secular trends such as a reduction in overcrowding or
improvements in access to care have contributed in part to the low prevalence of scabies in our
current survey. However, markers of broader secular development are largely unchanged in the
Solomon Islands since the original scabies intervention was completed. For example there has
been no increase in mean years of education or GDP per capita between 2000 and 2012 and the
UNDP Human development index for the Solomon Islands has not changed substantially
from the time of the original scabies intervention (HDI in year 2,000 = 0.475) to the time of the
current study (HDI in year 2013 = 0.491)[20]. Scabies has been reported to be cyclical in nature
in some countries[21], but this phenomenon is not observed in many tropical countries[21,22].
The ideal study design would have involved a control group of communities which did not
receive MDA and collecting data on scabies and impetigo both at baseline (1997–2000) and at
Table 2. Risk factors for impetigo.
Variable Prevalence Odds Ratio (95% CI)
Gender
Male 12.0% 2.0 (1.0–4.1)
Female 6.3% 1
Age (years)
12 12.4% 2.6 (1.2–5.9)
13–18 9.1% 1.8 (0.5–6.3)
19 5.2% 1
Household Size
5 9.6% 1
>5 7.4% 0.8 (0.3–1.6)
Individuals sleeping in same room (n)
1 3.4% 1
2 10.5% 3.4 (0.7–15.3)
3 9.2% 2.9 (0.7–12.8)
doi:10.1371/journal.pntd.0004246.t002
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the time of this follow-up survey (2015). As there were no control communities included in the
original survey such a study design was not possible. However, surveys conducted in two other
provinces of the Solomon Islands in the last year have observed prevalence of scabies that is
similar to that found in the study communities before MDA was conducted (Andrew Steer—
Personal Communication). Taken together, these data add weight to the argument that the low
prevalence of scabies and impetigo found in the current survey is attributable to the original
intervention and not to secular or cyclical trends in scabies prevalence.
We were not able to examine all individuals who were resident on the islands. Overall we
examined close to 70% of the population and the most frequently absent group of individuals
were adult males. As scabies is predominantly found in children, it seems unlikely that the
exclusion of older males has resulted in a significant under estimate of the prevalence of sca-
bies. At the time of the previous survey the population of the five communities was officially
recorded at 1,558 but only half of these individuals (approximately 750 people) were actually
reported to be resident on the islands. At the time of the current survey the resident population
of the communities had decreased slightly to 561 although officially the population of Sulofu
alone is close to 1,000. The majority of the children enrolled in this study were born after the
cessation of the scabies control programme and it seems unlikely therefore that the extremely
low prevalence of scabies is explained by herd immunity. Finally it is possible that examination
missed cases of scabies occurring in unexposed areas of the skin such as genitals or breasts. We
used the same exam exposure as was used in the original study[4] so it seems unlikely that this
contributed significantly to an under estimate of the prevalence of scabies.
Our data add to increasing evidence that community MDA with ivermectin is an effective
intervention for the control of scabies. The control strategy used in these communities included
additional interventions following the initial round of mass treatment. This is similar to the
World Health Organization strategy for the eradication of yaws[23], which also comprises an
initial round of community MDA, with azithromycin, followed by 6 monthly intensive case
finding and retreatment. Given the considerable epidemiological overlap between the two dis-
eases, especially in the Pacific[24], and the fact that a dermatological examination would allow
simultaneous surveillance for both diseases, an integrated approach should be considered for
these two neglected tropical diseases. Azithromycin and ivermectin have been safely co-admin-
istered as part of a study on integrated treatment for trachoma and lymphatic filariasis [25]
and larger scale studies would be of benefit in facilitating integrated control programmes.
The extremely low prevalence of scabies found in this study, despite the cessation of the sca-
bies control programme for more than 15 years, suggests that long-term disease control is a
realistic possibility. Large-scale studies of MDA and developing an evidence base to support
integration with other NTD control programmes should be priorities for the global control of
scabies worldwide.
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